Pfizer’s COVID-19 pill helps reduce COVID-19 hospitalizations and deaths in the elderly but provides no strong benefit for those under 65, according to a new study.
Researchers in Israel gleaned data from Clalit Health Services, a health care organization that covers over half of the entire population in the country.